Index by author

January 24, 2017 — Volume 135, Issue 4

A

  1. Alsiraj, Yasir

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  2. Ammash, Naser M.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  3. Arbetter, Douglas

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  4. Asirvatham, Samuel J.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  5. Atzler, Dorothee

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

B

  1. Bailey, Kent R.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  2. Becue, Frederic

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  3. Bhatt, Deepak L.

    1. O PIONEERs!The Beginning of the End of Full-Dose Triple Therapy with Warfarin?
      Deepak L. Bhatt
      Circulation. 2017;135:334-337, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025923

  4. Blalock, Eric

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  5. Bode, Christoph

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  6. Burrows, Sally

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  7. Burton, Paul

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

C

  1. Cassis, Lisa A.

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  2. Cha, Stephen S.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  3. Chan, Dick C.

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  4. Charnigo, Richard

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  5. Chen, Kuey

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  6. Chi, Gerald

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  7. Cohen, Marc

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  8. Cordts, Kathrin

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

  9. Cowan, Lisa

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

D

  1. Daaboul, Yazan

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  2. Daugherty, Alan

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  3. Dent, Ricardo

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

F

  1. Fatema, Kaniz

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  2. Fontanez, Nelson

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  3. Fox, Keith A.A.

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

G

  1. Garratt, Kirk N.

    1. Challenges in Risk Adjustment for Hospital and Provider Outcomes Assessment
      William S. Weintraub, Kirk N. Garratt
      Circulation. 2017;135:317-319, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025653

  2. Gersh, Bernard J.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  3. Gibson, C. Michael

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  4. Ginsberg, Henry N.

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

H

  1. Halperin, Jonathan

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  2. Holleran, Stephen

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

J

  1. Jain, Purva

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

K

  1. Karmally, Wahida

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  2. Korjian, Serge

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  3. Kuehn, Bridget M.

    1. Emerging Data Support Benefits of Yoga for Patients With Heart Disease
      Bridget M. Kuehn
      Circulation. 2017;135:398-399, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.026989

L

  1. Lee, Hon-Chi

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  2. Lichtenstein, Alice H.

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  3. Lip, Gregory Y.H.

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  4. Lygate, Craig A.

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

M

  1. Marcovina, Santica M.

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  2. Maroccia, Magali

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  3. Matta, James

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  4. Matthan, Nirupa R.

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  5. McAndrew, Debra J.

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

  6. Mehran, Roxana

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  7. Melduni, Rowlens M.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

N

  1. Nandakumar, Renu

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  2. Neubauer, Stefan

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

  3. Ngai, Colleen

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  4. Noseworthy, Peter A.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

O

  1. Obunike, Joseph

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

P

  1. Packard, Chris J.

    1. Unpacking and Understanding the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Apolipoprotein B Metabolism
      Chris J. Packard
      Circulation. 2017;135:363-365, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025897

  2. Packer, Douglas L.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  3. Pavlyha, Marianna

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  4. Peterson, Eric D.

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  5. Pinto, Duane S.

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  6. Poitiers, Franck

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

R

  1. R. Barrett, P. Hugh

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  2. Ramakrishnan, Rajasekhar

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  3. Reyes-Soffer, Gissette

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  4. Rihal, Charanjit S.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

S

  1. Sasiela, William J.

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  2. Schaff, Hartzell V.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  3. Schneider, Jürgen E.

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

  4. Schwedhelm, Edzard

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

  5. Scott, Rob

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  6. Seward, James B.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

  7. Somaratne, Ransi

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  8. Surks, Howard K.

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  9. Swanson, Brian

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

T

  1. Thatcher, Sean E.

    1. Female Mice With an XY Sex Chromosome Complement Develop Severe Angiotensin II–Induced Abdominal Aortic AneurysmsClinical Perspective
      Yasir Alsiraj, Sean E. Thatcher, Richard Charnigo, Kuey Chen, Eric Blalock, Alan Daugherty, Lisa A. Cassis
      Circulation. 2017;135:379-391, originally published November 4, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.023789

  2. Thomas, Tiffany

    1. Open Access
      Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
      Gissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, Tiffany Thomas, Stephen Holleran, Rajasekhar Ramakrishnan, Wahida Karmally, Renu Nandakumar, Nelson Fontanez, Joseph Obunike, Santica M. Marcovina, Alice H. Lichtenstein, Nirupa R. Matthan, James Matta, Magali Maroccia, Frederic Becue, Franck Poitiers, Brian Swanson, Lisa Cowan, William J. Sasiela, Howard K. Surks, Henry N. Ginsberg
      Circulation. 2017;135:352-362, originally published December 16, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025253

  3. Towler, Dwight A.

    1. Commonalities Between Vasculature and BoneAn Osseocentric View of Arteriosclerosis
      Dwight A. Towler
      Circulation. 2017;135:320-322, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.022562

V

  1. Verheugt, Freek W.A.

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

W

  1. Wasserman, Scott M.

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  2. Watts, Gerald F.

    1. Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismClinical Perspective
      Gerald F. Watts, Dick C. Chan, Ricardo Dent, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Sally Burrows, P. Hugh R. Barrett
      Circulation. 2017;135:338-351, originally published December 9, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025080
      CME

  3. Weintraub, William S.

    1. Challenges in Risk Adjustment for Hospital and Provider Outcomes Assessment
      William S. Weintraub, Kirk N. Garratt
      Circulation. 2017;135:317-319, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025653

  4. Wildgoose, Peter

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

  5. Wysokinski, Waldemar E.

    1. Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and MortalityClinical PerspectiveA Propensity Score–Matched Analysis of 10 633 Patients
      Rowlens M. Melduni, Hartzell V. Schaff, Hon-Chi Lee, Bernard J. Gersh, Peter A. Noseworthy, Kent R. Bailey, Naser M. Ammash, Stephen S. Cha, Kaniz Fatema, Waldemar E. Wysokinski, James B. Seward, Douglas L. Packer, Charanjit S. Rihal, Samuel J. Asirvatham
      Circulation. 2017;135:366-378, originally published November 30, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.021952

Y

  1. Yee, Megan

    1. Open Access
      Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
      C. Michael Gibson, Duane S. Pinto, Gerald Chi, Douglas Arbetter, Megan Yee, Roxana Mehran, Christoph Bode, Jonathan Halperin, Freek W.A. Verheugt, Peter Wildgoose, Paul Burton, Martin van Eickels, Serge Korjian, Yazan Daaboul, Purva Jain, Gregory Y.H. Lip, Marc Cohen, Eric D. Peterson, Keith A.A. Fox
      Circulation. 2017;135:323-333, originally published November 14, 2016
      https://doi.org/10.1161/CIRCULATIONAHA.116.025783

Z

  1. Zervou, Sevasti

    1. Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure
      Dorothee Atzler, Debra J. McAndrew, Kathrin Cordts, Jürgen E. Schneider, Sevasti Zervou, Edzard Schwedhelm, Stefan Neubauer, Craig A. Lygate
      Circulation. 2017;135:400-402, originally published January 23, 2017
      https://doi.org/10.1161/CIRCULATIONAHA.116.025673

This Issue

Search This Journal

Manage Table of Contents Alerts
Advertisement
Advertisement